Crystallization method and bioavailability

Details for Australian Patent Application No. 2010278860 (hide)

Owner Thar Pharmaceuticals, Inc.

Inventors Hanna, Mazen; Shan, Ning; Cheney, Miranda; Weyna, David; Houck, Raymond K.

Agent Allens Arthur Robinson

Pub. Number AU-A-2010278860

PCT Pub. Number WO2011/014766

Priority 61/302,110 06.02.10 US; 61/359,544 29.06.10 US; 61/318,503 29.03.10 US; 61/288,036 18.12.09 US; 61/312,879 11.03.10 US; 61/230,222 31.07.09 US

Filing date 30 July 2010

Wipo publication date 3 February 2011

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/04 (2006.01) Antineoplastic agents

C07F 9/6506 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

16 February 2012 PCT application entered the National Phase

  PCT publication WO2011/014766 Priority application(s): WO2011/014766

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010278867-Instrument for creating microfractures in a bone

2010278857-Device for detection of antigens and uses thereof